A.T.Kearney, the global management consultancy firm, has published a new White Paper on the pharmaceutical industry - Pharmaceuticals out of Balance.

The article presents evidence that the current pharmaceutical model may become irrelevant in the context of 21st century's global healthcare needs. The imbalance in the healthcare system, itself currently in urgent need of restructuring, is having a commensurate and major impact on the pharmaceutical industry. A.T. Kearney believes that this has brought the pharmaceutical industry to a tipping point -- indeed, three interconnected tipping points -- that will ultimately cause it to re-emerge in a radically different form. The white paper details these tipping points, outlining how they will relate to what the industry sells and to whom, and consequently, new models along which it could reorganize itself.

The three possible models that could emerge take pharmaceutical companies from therapies to service models, from niches to global mass markets and from integration to connection. Given the complexity of healthcare systems and treatment pathways, the challenge for pharmaceutical companies will be to decide on which therapy areas to focus and on which model to adopt.

In the paper, A.T. Kearney authors Jonathan Anscombe, Michael Thomas and Omar Sawaya outline a compelling vision for the future of the pharmaceutical industry, and a very real way for them to emerge from what experts are describing an industry at an impasse.

Download Pharmaceuticals out of Balance.